Anna Ewa Kozicz-Stankiewicz - Mar 1, 2023 Form 4 Insider Report for Cibus, Inc. (CBUS)

Role
Director
Signature
Suzette McNally, Attorney-in-Fact for Anna Ewa Kozicz-Stankiewicz
Stock symbol
CBUS
Transactions as of
Mar 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/1/2023, 07:50 PM
Previous filing
Jun 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -5K -100% 0 Mar 1, 2023 Common Stock 5K $4.55 Direct F1
transaction CBUS Stock Option (Right-to-Buy) Award +5K 5K Mar 1, 2023 Common Stock 5K $4.55 Direct F1
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -12.8K -100% 0 Mar 1, 2023 Common Stock 12.8K $4.22 Direct F1
transaction CBUS Stock Option (Right-to-Buy) Award +12.8K 12.8K Mar 1, 2023 Common Stock 12.8K $4.22 Direct F1
transaction CBUS Stock Option (Right-to-Buy) Disposed to Issuer -34.9K -100% 0 Mar 1, 2023 Common Stock 34.9K $0.30 Direct F1
transaction CBUS Stock Option (Right-to-Buy) Award +34.9K 34.9K Mar 1, 2023 Common Stock 34.9K $0.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Anna Ewa Kozicz-Stankiewicz is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.